Biogen (BIIB) Financials
Biogen (BIIB) Historical Financial Statements and Key Metrics for 1985 - 2021
Full Biogen financials for 1985 - 2021 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Biogen Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2021-Mar-31 | 2,694 | 2,216 (82.3 %) | 940 (34.9 %) | 410 (15.2 %) | 1,087 | 2.69 |
| 2020-Dec-31 | 2,853 | 2,362 (82.8 %) | -486 (-17.0 %) | 358 (12.5 %) | -396 | 2.28 |
| 2020-Sep-30 | 3,376 | 2,927 (86.7 %) | 1,057 (31.3 %) | 702 (20.8 %) | 1,191 | 4.46 |
| 2020-Jun-30 | 3,682 | 3,270 (88.8 %) | 1,984 (53.9 %) | 1,542 (41.9 %) | 2,097 | 9.59 |
| 2020-Mar-31 | 3,534 | 3,080 (87.1 %) | 1,890 (53.5 %) | 1,399 (39.6 %) | 2,010 | 8.08 |
| 2019-Dec-31 | 3,671 | 3,224 (87.8 %) | 1,740 (47.4 %) | 1,440 (39.2 %) | 1,853 | 8.08 |
| 2019-Sep-30 | 3,600 | 3,170 (88.1 %) | 1,731 (48.1 %) | 1,546 (42.9 %) | 2,061 | 8.39 |
Full historical income statements for 1985 - 2021 is included in the
US Historical Financials dataset.
Biogen Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2021-Mar-31 | 23,855 | 13,192 | 7,647 | 10,682 | 2,538 |
| 2020-Dec-31 | 24,619 | 13,933 | 14,852 | 10,686 | 2,610 |
| 2020-Sep-30 | 24,934 | 14,190 | 8,780 | 10,744 | 3,580 |
| 2020-Jun-30 | 25,512 | 14,223 | 9,366 | 11,289 | 4,328 |
| 2020-Mar-31 | 26,119 | 13,582 | 5,962 | 12,537 | 3,860 |
| 2019-Dec-31 | 27,234 | 13,895 | 5,955 | 13,339 | 4,476 |
| 2019-Sep-30 | 27,484 | 13,492 | 5,954 | 13,992 | 4,437 |
Full historical balance sheet data for 1985 - 2021 is included in the
US Historical Financials dataset.
Biogen Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2021-Mar-31 | 769 | -65 | -785 | 676 |
| 2020-Dec-31 | -367 | -166 | -401 | -468 |
| 2020-Sep-30 | 1,181 | -52 | -1,313 | 1,097 |
| 2020-Jun-30 | 1,948 | -833 | -1,313 | 1,844 |
| 2020-Mar-31 | 1,467 | 443 | -2,245 | 1,206 |
| 2019-Dec-31 | 1,960 | 708 | -2,116 | 1,695 |
| 2019-Sep-30 | 1,695 | -366 | -689 | 1,605 |
Full historical cash flow data for 1985 - 2021 is included in the
US Historical Financials dataset.
Biogen Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2021-Mar-31 | 42,494 | 48,544 | 15.77 | 25.90 | 3.98 |
| 2020-Dec-31 | 38,419 | 51,940 | 13.47 | 26.84 | 3.60 |
| 2020-Sep-30 | 44,509 | 49,710 | 13.18 | 15.86 | 4.14 |
| 2020-Jun-30 | 42,969 | 48,007 | 11.67 | 6.97 | 3.81 |
| 2020-Mar-31 | 54,670 | 58,041 | 15.47 | 9.77 | 4.36 |
| 2019-Dec-31 | 52,759 | 55,800 | 14.37 | 9.16 | 3.96 |
| 2019-Sep-30 | 42,839 | 46,448 | 11.90 | 6.93 | 3.06 |
Full historical valuation and operating metrics for 1985 - 2021 are included in the
US Historical Financials dataset.